NCT01527318View on ClinicalTrials.gov

The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Neutral Lipid Storage Disease
Interventions
DRUG

Fibrate treatment

Patients will receive a dosage of 400mg Bezafibrate every day during 28 weeks

Trial Locations (1)

6200MD

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT01527318 - The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM) | Biotech Hunter | Biotech Hunter